Oscotec Financial Statements From 2010 to 2024

039200 Stock  KRW 23,350  650.00  2.71%   
Oscotec financial statements provide useful quarterly and yearly information to potential Oscotec investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Oscotec financial statements helps investors assess Oscotec's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Oscotec's valuation are summarized below:
Oscotec does not presently have any trending fundamental ratios for analysis.
Check Oscotec financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oscotec's main balance sheet or income statement drivers, such as , as well as many indicators such as . Oscotec financial statements analysis is a perfect complement when working with Oscotec Valuation or Volatility modules.
  
This module can also supplement various Oscotec Technical models . Check out the analysis of Oscotec Correlation against competitors.

Oscotec Company Current Valuation Analysis

Oscotec's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Oscotec Current Valuation

    
  996.59 B  
Most of Oscotec's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oscotec is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Oscotec has a Current Valuation of 996.59 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.

Oscotec Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Oscotec's current stock value. Our valuation model uses many indicators to compare Oscotec value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oscotec competition to find correlations between indicators driving Oscotec's intrinsic value. More Info.
Oscotec is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Oscotec by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Oscotec's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Oscotec Financial Statements

Oscotec stakeholders use historical fundamental indicators, such as Oscotec's revenue or net income, to determine how well the company is positioned to perform in the future. Although Oscotec investors may analyze each financial statement separately, they are all interrelated. For example, changes in Oscotec's assets and liabilities are reflected in the revenues and expenses on Oscotec's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Oscotec. Please read more on our technical analysis and fundamental analysis pages.
Oscotec Inc. operates as a clinical stage drug discovery and development company. Oscotec Inc. was founded in 1988 and is based in Seongnam, South Korea. OCT is traded on Korean Securities Dealers Automated Quotations in South Korea.

Other Information on Investing in Oscotec Stock

Oscotec financial ratios help investors to determine whether Oscotec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oscotec with respect to the benefits of owning Oscotec security.